hormonal peptides, can be considered mucosal in nature. These observations may explain the primitive origin of the MALT lymphoma in the thymus. The morphological features of the submandibular gland-that is, expansion of the lymphoid infiltrate and the presence of blast forms of CCL cells, are diagnostic of a lymphomatous process and genetic analysis demonstrated a K chain rearrangement. The morphological and genotypic analyses are consistent with a diagnosis of B cell low grade malignant lymphoma of the salivary gland2 exhibiting features of a MALT lymphoma. As the salivary gland normally lacks lymphoid tissue, the MALT lymphoma may have originated from tissue involved by MESA. However, there was no evidence of underlying MESA in our patient. The infiltrate of the skin was composed of a few clear CCL cells and many monotypic IgA/ic plasma cells. Plasma cell differentiation was associated with amyloid deposits. The presence of CCL cells and the monoclonality of the plasma cells suggest that the cutaneous infiltrate originated via the same lymphomatous process.
It is of note that the lesions in the salivary gland and the thymus were histologically similar and also had identical clonally rearranged bands. The morphological features of MALT lymphoma in the salivary gland and the thymus have been reported previously.3 It is possible that multiple mucosal sites can be involved by MALT lymphoma or that the lymphoma can spread from the salivary gland to the thymus. This pattern of spread probably depends on the specific circulation pathways and homing characteristics of the lymphocytes present. We can put forward two hypotheses: (1) that the B lymphocytes of the thymus and salivary gland are closely related; and (2) that B lymphocytes can move between these two organs. Similarly, the lymphomatous localisation in the skin could have resulted from peripheral spread of the tumours and could be related, at the least in part, to lymphocyte-endothelial cell recognition. Skin directly exposed to the external environment may be a site for so-called acquired B cell, skin associated lymphoid tissue. Cutaneous B cell lymphomas have numerous aspects in common with MALT lymphoma, not least being originated from lymphoid tissue.'0
In conclusion, our case is unique because the patient has evidence of MALT lymphoma in the salivary gland and in the thymus showing the same genotypic pattern, with further localisation in the skin. This confirms the possibility of multiple mucosal sites involved by lymphoma or the spread of a MALT lymphoma from one mucosal site to another, including the skin. Results and Discussion Tables 1 and 2 summarise the results. If the kappa value is less than one, then we are 100% sure that performance is less than perfect and the upper confidence limit must also be less than one. In practice, however, methods of calculating confidence limits are approximate and high kappa values do have calculated upper limits of one when standard methods are used. Thus, to show by calculation that performance is significantly (p < 0.05) below a very high level (close to perfection) the calculated upper confidence limit must be less than one. At all population sizes and mixes in the present study, however, the number of false positive results required to produce an upper confidence limit below one was unacceptably high. The Cytology Subgroup of the National Coordinating Committee for Breast Screening Pathology recommend that the false positive rate should be less than 1 %,6 but in this study the upper confidence limit of the kappa statistic fell below one, with a false positive rate of less than 1% only in populations with 800 and 1600 cases in a 50:50 population mix (rows 5 and 6 of table 1) and in the population of 1600 cases in the 80:20 mix (row 6 of table 2). Population numbers of 800 and 1600 represent the number of fine needle aspirates of the breast a pathologist might see during one or two years in a busy laboratory rather than the number of specimens that could be included in a quality assurance scheme.
The model used in this study is the simplest that could occur in pathology with a dichotomous outcome that can be verified (by clinical examination, mammography, histology, and follow up). Most other diagnostic situations in pathology would involve more diagnostic outcomes and those outcomes would be less easily verified (for example, diagnosis of inflammatory bowel disease by colorectal biopsy7 or assessment of chronic gastritis8 ). A greater number of diagnostic outcomes would produce wider confidence limits for the kappa statistics if the population size remained the same.9 It therefore seems than the kappa statistic is not a sensitive indicator of performance in cytopathological or histopathological quality assurances schemes unless large numbers of samples are used. Other indicators should be considered, possibly using systems which weight the outcomes according to the importance of the result in clinical practice.'0 The present study did not include the function of time and the persistence of low kappa statistics over a number of cycles of a quality assurance scheme would be a more reliable indicator of possible unsatisfactory performance. However, the frequency of cycles in most schemes is such that at least two years would elapse before such an assessment would be possible.
